Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Diagnostic Laboratory, |
RCV000203152 | SCV000257602 | likely benign | not specified | 2015-02-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311312 | SCV000846882 | benign | Inborn genetic diseases | 2016-06-16 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000608121 | SCV001733190 | benign | Adrenoleukodystrophy | 2024-11-21 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000608121 | SCV002045873 | benign | Adrenoleukodystrophy | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003967540 | SCV004792651 | likely benign | ABCD1-related disorder | 2022-12-15 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |